LAB Q2 2018 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

Q2 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$26M+10.5% YoY

Gross Profit

$14M51.4% margin

Operating Income

-$13M-48.4% margin

Net Income

-$16M-61.5% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

+4.7%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$259M

Total Liabilities

$224M

Stockholders' Equity

$35M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26M	$24M	+10.5%
Gross Profit	$14M	$12M	+13.7%
Operating Income	-$13M	-$16M	+22.5%
Net Income	-$16M	-$17M	+4.1%

Revenue Segments

Total Products

$22M45%

Consumables

$11M24%

Instruments

$10M22%

Services

$5M10%

Geographic Segments

UNITED STATES

$12M46%

Europe

$9M34%

Asia Pacific

$5M18%

Other Geographical Countries

$478,0002%